Researchers at Pacific University’s College of Optometry are seeking children aged 3 to 10 who are nearsighted in both eyes to participate in a national study of ways to slow the progression of the condition.
The CHAMP Study(Childhood Atropine for Myopia Progression) is a multi-center FDA drug trial that studies the safety and effectiveness of low-dose atropine eye drops that are intended to stop nearsightedness from worsening.
Nearsightedness, or myopia, occurs when the eyeball’s shape or other anomaly causes light to focus somewhere short of the retina. This can cause distant images to appear blurry and out of focus.
Researchers at Pacific and elsewhere are exploring ways to slow or stop this trend. “We want to catch kids as early as possible,” said Pacific CHAMP Study project lead and associate professor Chunming Liu OD, PhD.
Parents whose children have been diagnosed with myopia in both eyes are eligible to participate in the four-year study. Participants will receive all study-related visits, eye exams, and eye drops for free, along with a yearly allowance for glasses and/or contact lenses.
Lead Research/InvestigatorSource: The CHAMP Study